| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P356 | DOI | 10.1016/S0029-7844(98)00139-2 |
| P698 | PubMed publication ID | 9721791 |
| P50 | author | Karla Kerlikowske | Q92299671 |
| P2093 | author name string | D Grady | |
| L Subak | |||
| P P Garg | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian carcinoma | Q18556145 |
| Hormone Replacement Therapy | Q108667313 | ||
| meta-analysis | Q815382 | ||
| P304 | page(s) | 472-479 | |
| P577 | publication date | 1998-09-01 | |
| P1433 | published in | Obstetrics and Gynecology | Q7075543 |
| P1476 | title | Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis | |
| P478 | volume | 92 |
| Q64130667 | A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancer |
| Q28213056 | A prospective study of postmenopausal hormone use and ovarian cancer risk |
| Q36152737 | Bisphenol A and hormone-associated cancers: current progress and perspectives |
| Q36106730 | Chemotherapy-induced ovarian failure: manifestations and management |
| Q26822648 | Clinical epidemiology of epithelial ovarian cancer in the UK |
| Q28535464 | Comparison of pooled risk estimates for adverse effects from different observational study designs: methodological overview |
| Q37551696 | Current understanding of risk factors for ovarian cancer |
| Q38363908 | Differential expression of progesterone receptor isoforms A and B in the normal ovary, and in benign, borderline, and malignant ovarian tumors |
| Q38499888 | Does ovarian stimulation for IVF increase gynaecological cancer risk? A systematic review and meta-analysis |
| Q36947200 | Dynamic monitoring of menopause hormone therapy and defining the cut-off value of endometrial thickness during uterine bleeding |
| Q37720438 | Epidemiology of ovarian cancer: a review |
| Q46011803 | Epithelial ovarian cancer risk by invasiveness and cell type in the Central Valley of California. |
| Q33826212 | Estrogen responsiveness of the TFIID subunit TAF4B in the normal mouse ovary and in ovarian tumors |
| Q34022694 | Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer |
| Q35840390 | Estrogens and epithelial ovarian cancer |
| Q33932063 | Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings |
| Q36367092 | Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells |
| Q34976443 | Gynecology: select topics |
| Q34602929 | Hormone replacement therapy (HRT) in women after genital cancer |
| Q80552811 | Hormone replacement therapy and ovarian cancer risk: a meta-analysis |
| Q36619751 | Hormone replacement therapy and risk of epithelial ovarian cancer. |
| Q37312757 | Hormone therapy and ovarian cancer: incidence and survival |
| Q35216824 | Hot flashes in breast cancer survivors |
| Q36159386 | Menopausal hormone therapy and ovarian cancer |
| Q34341910 | Menopause, hormone replacement therapy and cancer |
| Q33894784 | Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview |
| Q37293672 | Molecular pathogenesis of endometrial and ovarian cancer |
| Q35948695 | Neoplasia of the female reproductive tract: effects of hormone therapy |
| Q37147427 | Proliferation of the superficial epithelium of ovaries in senile female rats following oral administration of conjugated equine estrogens |
| Q34268606 | Reproductive and hormonal factors in association with ovarian cancer in the Netherlands cohort study. |
| Q34920036 | Reproductive hormones and cancer: ovarian and colon cancer |
| Q27011949 | Salpingectomy as a means to reduce ovarian cancer risk |
| Q83956699 | Soy isoflavones attenuate bone loss in early postmenopausal Chinese women : a single-blind randomized, placebo-controlled trial |
| Q33940373 | Systematic review and meta-analysis in anatomic pathology |
| Q34254787 | Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended event |
| Q37567078 | Targeted treatment of folate receptor-positive platinum-resistant ovarian cancer and companion diagnostics, with specific focus on vintafolide and etarfolatide |
| Q26866045 | Targeting TBP-Associated Factors in Ovarian Cancer |
| Q57288786 | The Evolution of Estrogen Receptor Signaling in the Progression of Endometriosis to Endometriosis-Associated Ovarian Cancer |
| Q33688763 | The adverse effects of hormone replacement therapy |
| Q35676052 | The epidemiology of endometrial and ovarian cancer |
| Q34364786 | The wisdom of hormone-replacement therapy in survivors of ovarian and endometrial cancer |
| Q91774033 | To evaluate the efficacy and safety of PLC in perimenopausal or postmenopausal women with Hot Flashes: study protocol for a randomized controlled trial |
| Q79175056 | [Postmenopausal osteoporosis. Clinical practice guide] |
Search more.